Vitalität von Indianapolis

BioCrossroads fördert Zusammenarbeit und Wachstum im Biowissenschaftssektor von Indiana

Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Gesundheit

Can Schools Play a Role in Helping to Address Indiana’s Opioid Crisis?

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. There are many important efforts underway across Indiana to tackle the opioid epidemic. Stakeholders in the public, private and non-profit sectors – first responders, health systems, government agencies, employers and others – are allocating significant resources to help Hoosiers struggling with addiction […]

READ MORE
Gesundheit

Tobacco 21 and the Military—Old Enough to Fight but Not Old Enough to Smoke?

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. Smoking remains the leading cause of preventable death nationwide. In Indiana, which has among the highest smoking rates in the U.S., an estimated 11,000 people die each year from smoking. While smoking-related illnesses generally occur in older ages, smoking starts […]

READ MORE